▶ 調査レポート

世界のブリスターパック医薬製品市場2020年-2030年:医薬品タイプ別(錠剤、カプセル)、製造プロセス別、エンドユーザー別

• 英文タイトル:Blister Pack Pharmaceutical Products Market (Drug Type: Tablets and Capsules; Manufacturing Process: Cold Forming and Thermoforming; and End Use: Pharmaceuticals, Nutraceuticals and Supplements, and Veterinary Drugs) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。世界のブリスターパック医薬製品市場2020年-2030年:医薬品タイプ別(錠剤、カプセル)、製造プロセス別、エンドユーザー別 / Blister Pack Pharmaceutical Products Market (Drug Type: Tablets and Capsules; Manufacturing Process: Cold Forming and Thermoforming; and End Use: Pharmaceuticals, Nutraceuticals and Supplements, and Veterinary Drugs) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / MRC21A11資料のイメージです。• レポートコード:MRC21A11
• 出版社/出版日:Transparency Market Research / 2020年12月3日
• レポート形態:英文、PDF、170ページ
• 納品方法:Eメール
• 産業分類:包装
• 販売価格(消費税別)
  Single User¥614,270 (USD5,795)▷ お問い合わせ
  Site Licence (同一拠点内共用可)¥932,270 (USD8,795)▷ お問い合わせ
  Enterprise wide(複数拠点共用可)¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界のブリスターパック医薬製品市場について調査し、エグゼクティブサマリー、市場イントロダクション、市場観点、新型コロナウイルス感染症による影響、製品市場分析、医薬品タイプ別(錠剤、カプセル)分析、製造プロセス別分析、エンドユーザー別分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東アフリカ)分析、市場構造分析、競争状況、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場イントロダクション
・市場観点
・新型コロナウイルス感染症による影響
・製品市場分析
・世界のブリスターパック医薬製品市場規模:医薬品タイプ別(錠剤、カプセル)
・世界のブリスターパック医薬製品市場規模:製造プロセス別
・世界のブリスターパック医薬製品市場規模:エンドユーザー別
・世界のブリスターパック医薬製品市場規模:地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東アフリカ)
・市場構造分析
・競争状況
・仮定
・調査手法

Blister Pack Pharmaceutical Products Market – Scope of the Report
Transparency Market Research (TMR) started a new study on the global blister pack pharmaceutical products market, providing forecast for the period of 2020-2030. In the study, growth opportunity for the blister pack pharmaceutical products market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the blister pack pharmaceutical products market, untapped opportunities for manufacturers, trends and developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.

Key Questions Answered in TMR’s Blister Pack Pharmaceutical Products Market Report
What will be market size for blister pack pharmaceutical products by the end of 2030?
What will be the impact of COVID-19 on blister pack pharmaceutical products market?
Which is the most preferred manufacturing process for packaging of blister packed pharmaceutical products in the global market?
Which region will remain most lucrative for market growth?
Which end use segment holds maximum market share of the global blister pack pharmaceutical products market?
Who are major key players in the blister pack pharmaceutical products market?
Key indicators associated with the blister pack pharmaceutical products market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global blister pack pharmaceutical products market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users have been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of blister pack pharmaceutical products. Furthermore, forecast factors and forecast scenarios of the blister pack pharmaceutical products market have been covered in the report to understand future prospects of the market.

A comprehensive evaluation and forecast on the blister pack pharmaceutical products market are provided on the drug type, manufacturing process, end use, and region.

Y-o-Y growth comparison, revenue comparison, and market share comparison of various market segments are provided in the report. The blister pack pharmaceutical products market is analyzed at both regional and country levels.

The report delivers an exhaustive assessment on the structure of the blister pack pharmaceutical products market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of blister pack pharmaceutical products manufacturers by leveraging an intensity map. It also highlights key end users for blister pack pharmaceutical products.

The report includes company overview of key players. Some of the key companies profiled in the blister pack pharmaceutical products market report include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Sun Pharmaceutical Industries Ltd, Cadila Healthcare, etc.

Research Methodology
A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the blister pack pharmaceutical products market for the study evaluation period. The TMR report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.

Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the blister pack pharmaceutical products market. The report has further undergone a cross-validation by in-house professionals to make the blister pack pharmaceutical products market report one-of-its-kind with the highest credibility.

レポート目次

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. TMR Analysis and Recommendations

1.4. Opportunity Analysis

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Market Viewpoint

3.1. Global Economic Outlook

3.2. Global Pharmaceutical Market Overview

3.3. Macro-Economic Factors and Co-relation Analysis

3.4. Forecast Factors – Relevance and Impact

3.5. Value Chain Analysis

3.5.1. Exhaustive List of Active Participants

3.5.1.1. Raw Material Suppliers

3.5.1.2. Manufacturers

3.5.1.3. Distributers/End Users

3.5.2. Profitability Margins

4. Impact of COVID-19

4.1.1. Current Statistics and Probable Future Impact

4.1.2. Current Economic Projection – GDP/GVA and Probable Impact

4.1.3. Comparison of SAARs and Market Recovery, for Key Countries

4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries

4.1.5. Impact of COVID-19 on Blister Pack Pharmaceutical Products Market

5. Blister Pack Pharmaceutical Products Market Analysis

5.1. Market Value (US$ Mn) and Analysis & Forecast

5.2. Y-o-Y Growth Projections

5.3. Absolute $ Opportunity Analysis

6. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Drug Type

6.1. Section Summary

6.2. Introduction

6.2.1. Market share and Basis Points (BPS) Analysis By Drug Type

6.2.2. Y-o-Y Growth Projections By Drug Type

6.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

6.3.1. Tablets

6.3.2. Capsules

6.4. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

6.4.1. Tablets

6.4.2. Capsules

6.5. Market Attractiveness Analysis By Drug Type

7. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Manufacturing Process

7.1. Section Summary

7.2. Introduction

7.2.1. Market share and Basis Points (BPS) Analysis By Manufacturing Process

7.2.2. Y-o-Y Growth Projections By Manufacturing Process

7.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

7.3.1. Cold Forming

7.3.2. Thermoforming

7.4. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

7.4.1. Cold Forming

7.4.2. Thermoforming

7.5. Market Attractiveness Analysis By Manufacturing Process

8. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By End Use

8.1. Section Summary

8.2. Introduction

8.2.1. Market share and Basis Points (BPS) Analysis By End Use

8.2.2. Y-o-Y Growth Projections End Use

8.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

8.3.1. Pharmaceuticals

8.3.2. Nutraceuticals and Supplements

8.3.3. Veterinary Drugs

8.4. Market Size (US$ Mn) Forecast 2020-2030, By End Use

8.4.1. Pharmaceuticals

8.4.2. Nutraceuticals and Supplements

8.4.3. Veterinary Drugs

8.5. Market Attractiveness Analysis By End Use

9. Global Blister Pack Pharmaceutical Products Market Analysis and Forecast, By Region

9.1. Section Summary

9.2. Introduction

9.2.1. Market share and Basis Points (BPS) Analysis By Region

9.2.2. Y-o-Y Growth Projections By Region

9.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Region

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia Pacific

9.3.5. Middle East and Africa (MEA)

9.4. Market Size (US$ Mn) Forecast 2020-2030 By Region

9.4.1. North America

9.4.2. Latin America

9.4.3. Europe

9.4.4. Asia Pacific

9.4.5. Middle East and Africa (MEA)

9.5. Market Attractiveness Analysis By Region

10. North America Blister Pack Pharmaceutical Products Market Analysis and Forecast

10.1. Section Summary

10.2. Introduction

10.2.1. Market share and Basis Points (BPS) Analysis By Country

10.2.2. Y-o-Y Growth Projections By Country

10.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

10.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

10.4.1. U.S.

10.4.2. Canada

10.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

10.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

10.6.1. Tablets

10.6.2. Capsules

10.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

10.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

10.8.1. Cold Forming

10.8.2. Thermoforming

10.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

10.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

10.10.1. Pharmaceuticals

10.10.2. Nutraceuticals and Supplements

10.10.3. Veterinary Drugs

10.11. Prominent Trends

11. Latin America Blister Pack Pharmaceutical Products Market Analysis and Forecast

11.1. Section Summary

11.2. Introduction

11.2.1. Market share and Basis Points (BPS) Analysis By Country

11.2.2. Y-o-Y Growth Projections By Country

11.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

11.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

11.4.1. Brazil

11.4.2. Mexico

11.4.3. Argentina

11.4.4. Rest of Latin America

11.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

11.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

11.6.1. Tablets

11.6.2. Capsules

11.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

11.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

11.8.1. Cold Forming

11.8.2. Thermoforming

11.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

11.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

11.10.1. Pharmaceuticals

11.10.2. Nutraceuticals and Supplements

11.10.3. Veterinary Drugs

11.11. Prominent Trends

12. Europe Blister Pack Pharmaceutical Products Market Analysis and Forecast

12.1. Section Summary

12.2. Introduction

12.2.1. Market share and Basis Points (BPS) Analysis By Country

12.2.2. Y-o-Y Growth Projections By Country

12.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

12.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

12.4.1. Germany

12.4.2. Spain

12.4.3. Italy

12.4.4. France

12.4.5. U.K.

12.4.6. BENELUX

12.4.7. NORDIC

12.4.8. Russia

12.4.9. Poland

12.4.10. Rest of Europe

12.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

12.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

12.6.1. Tablets

12.6.2. Capsules

12.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

12.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

12.8.1. Cold Forming

12.8.2. Thermoforming

12.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

12.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

12.10.1. Pharmaceuticals

12.10.2. Nutraceuticals and Supplements

12.10.3. Veterinary Drugs

12.11. Prominent Trends

13. Asia Pacific Blister Pack Pharmaceutical Products Market Analysis and Forecast

13.1. Section Summary

13.2. Introduction

13.2.1. Market share and Basis Points (BPS) Analysis By Country

13.2.2. Y-o-Y Growth Projections By Country

13.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

13.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

13.4.1. China

13.4.2. India

13.4.3. Japan

13.4.4. ASEAN

13.4.5. Australia and New Zealand

13.4.6. Rest of APAC

13.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

13.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

13.6.1. Tablets

13.6.2. Capsules

13.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

13.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

13.8.1. Cold Forming

13.8.2. Thermoforming

13.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

13.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

13.10.1. Pharmaceuticals

13.10.2. Nutraceuticals and Supplements

13.10.3. Veterinary Drugs

13.11. Prominent Trends

14. Middle East and Africa Blister Pack Pharmaceutical Products Market Analysis and Forecast

14.1. Section Summary

14.2. Introduction

14.2.1. Market share and Basis Points (BPS) Analysis By Country

14.2.2. Y-o-Y Growth Projections By Country

14.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country

14.4. Market Size (US$ Mn) Forecast 2020-2030 By Country

14.4.1. GCC countries

14.4.2. Northern Africa

14.4.3. South Africa

14.4.4. Turkey

14.4.5. Rest of MEA

14.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type

14.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type

14.6.1. Tablets

14.6.2. Capsules

14.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process

14.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process

14.8.1. Cold Forming

14.8.2. Thermoforming

14.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use

14.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use

14.10.1. Pharmaceuticals

14.10.2. Nutraceuticals and Supplements

14.10.3. Veterinary Drugs

14.11. Prominent Trends

15. Market Structure Analysis

15.1. Market Analysis, by Tier of Companies

15.2. Market Concentration

15.3. Market Presence Analysis

16. Competitive Landscape

16.1. Competition Dashboard

16.2. Company Market Share Analysis

16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)

16.4. Competition Deep Dive

16.4.1.1. Pfizer Inc

16.4.1.1.1. Overview

16.4.1.1.2. Product Portfolio

16.4.1.1.3. Profitability

16.4.1.1.4. Sales Footprint

16.4.1.1.5. Competition Benchmarking

16.4.1.1.6. Strategy

16.4.1.1.6.1. Marketing Strategy

16.4.1.1.6.2. Product Strategy

16.4.1.1.6.3. Channel Strategy

16.4.1.2. GlaxoSmithKline plc

16.4.1.2.1. Overview

16.4.1.2.2. Product Portfolio

16.4.1.2.3. Profitability

16.4.1.2.4. Sales Footprint

16.4.1.2.5. Competition Benchmarking

16.4.1.2.6. Strategy

16.4.1.2.6.1. Marketing Strategy

16.4.1.2.6.2. Product Strategy

16.4.1.2.6.3. Channel Strategy

16.4.1.3. Sanofi

16.4.1.3.1. Overview

16.4.1.3.2. Product Portfolio

16.4.1.3.3. Profitability

16.4.1.3.4. Sales Footprint

16.4.1.3.5. Competition Benchmarking

16.4.1.3.6. Strategy

16.4.1.3.6.1. Marketing Strategy

16.4.1.3.6.2. Product Strategy

16.4.1.3.6.3. Channel Strategy

16.4.1.4. Roche Holding AG

16.4.1.4.1. Overview

16.4.1.4.2. Product Portfolio

16.4.1.4.3. Profitability

16.4.1.4.4. Sales Footprint

16.4.1.4.5. Competition Benchmarking

16.4.1.4.6. Strategy

16.4.1.4.6.1. Marketing Strategy

16.4.1.4.6.2. Product Strategy

16.4.1.4.6.3. Channel Strategy

16.4.1.5. Novartis AG

16.4.1.5.1. Overview

16.4.1.5.2. Product Portfolio

16.4.1.5.3. Profitability

16.4.1.5.4. Sales Footprint

16.4.1.5.5. Competition Benchmarking

16.4.1.5.6. Strategy

16.4.1.5.6.1. Marketing Strategy

16.4.1.5.6.2. Product Strategy

16.4.1.5.6.3. Channel Strategy

16.4.1.6. Allergan

16.4.1.6.1. Overview

16.4.1.6.2. Product Portfolio

16.4.1.6.3. Profitability

16.4.1.6.4. Sales Footprint

16.4.1.6.5. Competition Benchmarking

16.4.1.6.6. Strategy

16.4.1.6.6.1. Marketing Strategy

16.4.1.6.6.2. Product Strategy

16.4.1.6.6.3. Channel Strategy

16.4.1.7. Johnson & Johnson

16.4.1.7.1. Overview

16.4.1.7.2. Product Portfolio

16.4.1.7.3. Profitability

16.4.1.7.4. Sales Footprint

16.4.1.7.5. Competition Benchmarking

16.4.1.7.6. Strategy

16.4.1.7.6.1. Marketing Strategy

16.4.1.7.6.2. Product Strategy

16.4.1.7.6.3. Channel Strategy

16.4.1.8. Merck

16.4.1.8.1. Overview

16.4.1.8.2. Product Portfolio

16.4.1.8.3. Profitability

16.4.1.8.4. Sales Footprint

16.4.1.8.5. Competition Benchmarking

16.4.1.8.6. Strategy

16.4.1.8.6.1. Marketing Strategy

16.4.1.8.6.2. Product Strategy

16.4.1.8.6.3. Channel Strategy

16.4.1.9. Sun Pharmaceutical Industries Ltd

16.4.1.9.1. Overview

16.4.1.9.2. Product Portfolio

16.4.1.9.3. Profitability

16.4.1.9.4. Sales Footprint

16.4.1.9.5. Competition Benchmarking

16.4.1.9.6. Strategy

16.4.1.9.6.1. Marketing Strategy

16.4.1.9.6.2. Product Strategy

16.4.1.9.6.3. Channel Strategy

16.4.1.10. Cadila Healthcare

16.4.1.10.1. Overview

16.4.1.10.2. Product Portfolio

16.4.1.10.3. Profitability

16.4.1.10.4. Sales Footprint

16.4.1.10.5. Competition Benchmarking

16.4.1.10.6. Strategy

16.4.1.10.6.1. Marketing Strategy

16.4.1.10.6.2. Product Strategy

16.4.1.10.6.3. Channel Strategy

17. Assumptions and Acronyms

18. Research Methodology

List of Tables

Table 01: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 02: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 03: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 04: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region

Table 05: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 06: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 07: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 08: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 09: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 10: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 11: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 12: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 13: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 14: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 15: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 16: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 17: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 18: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 19: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 20: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country

Table 21: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type

Table 22: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process

Table 23: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use

Table 24: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country value (US$ Bn) 2015H-2030F, by Drug Type